Why a single molecule called CD166 could unlock new cancer therapies
More than $ 3 million from the National Institutes of Health will allow Indiana University Melvin and Bren Simon Cancer Center researchers to improve understanding of the complex system of how hematopoietic stem cells (HSC) survive and sustain their function in the bone marrow. Edward F. Srour, Ph.D., the Robert J. and Annie S. Rohn… Read More »